1. Industries
  2. Biotechnology companies

Biotechnology Companies & Verified Decision-Maker Emails

Biotechnology companies research and develop pharmaceuticals, diagnostics, genetic engineering, and life sciences innovations. Procurement cycles often involve research directors, lab executives, and founders.

Connect with biotech organizations scaling clinical research, product commercialization, and scientific innovation.

Identify and research relevant companies and decision-makers in the Biotechnology sector. Access verified business emails and direct contact details to support targeted lead generation, outreach campaigns, and higher conversion rates. Filter prospects by location, category, company size, and operating status to build precise, high-quality lists.

🔥 Why Use Our Directory?

Built for Real B2B Growth

Trusted by SDRs, agencies & founders who need verified, export-ready data.

📧

95%+ Email Verification Rate

Highly accurate contact data to minimize bounce rates and safeguard sender reputation.

🔄

Weekly Database Updates

Fresh company and contact records updated continuously.

🎯

Advanced Filtering

Filter by industry, country, company size & funding stage.

📊

Export-Ready CSV

Download clean, structured CSV files ready for your CRM or outreach tool.

Explore Plans

Companies

Found 391 firms

Prospects

Found 971 prospects · 157 Decision-Makers

Search Results

Showing 1–20 of 391 verified Biotechnology companies — browse profiles, find decision-makers, and export contacts.

AbbVie

abbvie.com

HQ: North Chicago, Illinois, United States

HQ: North Chicago, Illinois, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 22, 2024
Founded Date: 2013
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NYSE:ABBV
Operating Status: Active

  • Melanie Cohen

    m***********n@abbvie.com

  • Nancy Vangeys

    n***********s@abbvie.com

  • Customer Service

    customerservice@abbvie.com

  • Unclassified inbox

    talentacquisition@abbvie.com

Show more 311 emails
View AbbVie Profile Verify AbbVie Emails Export AbbVie Prospects

Medtronic

medtronic.com

HQ: Minneapolis, MN

HQ: Minneapolis, MN

Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Medical Devices, Hospitals & Clinics

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 27, 2024
Founded Date: 1949
Number of Exits: 28
Company Type: For Profit
Stock Symbol: NYSE:MDT
Operating Status: Active

  • Omar Ishrak

    CEO

    o**r@medtronic.com

  • Markowski

    Senior Manager

    m*******i@medtronic.com

  • Unclassified inbox

    michelle.r.claypool@medtronic.com

  • Unclassified inbox

    RS.MedtronicAcademy@medtronic.com

Show more 49 emails
View Medtronic Profile Verify Medtronic Emails Export Medtronic Prospects

Pfizer Venture Investments

pfizer.com

HQ: New York, NY

HQ: New York, NY

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 3, 2024
Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital

  • Rebecca Hamm

    Senior Director, Communications

    r**********m@pfizer.com

  • Christopher Conner

    US Field Medical Excellence Vaccines + Antivirals

    c****************r@pfizer.com

  • Unclassified inbox

    samuel.thevasagayam@pfizer.com

  • General Inquiries

    alfredo.chi@pfizer.com

Show more 43 emails
View Pfizer Venture Investments Profile Verify Pfizer Venture Investments Emails Export Pfizer Venture Investments Prospects

Merck

merck.com

HQ: Rahway, New Jersey, United States

HQ: Rahway, New Jersey, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: 1891
Number of Exits: 9
Company Type: For Profit
Stock Symbol: NYSE:MRK
Operating Status: Active

  • Phillip Samayoa

    Associate Director, MRL Ventures

    p******s@merck.com

  • Joseph Schaller

    j*************r@merck.com

  • Unclassified inbox

    estanislao_meza@merck.com

  • Unclassified inbox

    alain_boisvert@merck.com

Show more 42 emails
View Merck Profile Verify Merck Emails Export Merck Prospects

Pfizer

pfizer.com

HQ: New York, NY

HQ: New York, NY

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 9, 2024
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital

  • Rebecca Hamm

    Senior Director, Communications

    r**********m@pfizer.com

  • Christopher Conner

    US Field Medical Excellence Vaccines + Antivirals

    c****************r@pfizer.com

  • General Inquiries

    info@pfizer.com

Show more 40 emails
View Pfizer Profile Verify Pfizer Emails Export Pfizer Prospects

Novo Nordisk

novonordisk.com

HQ: Bagsværd, Hovedstaden, Denmark

HQ: Bagsværd, Hovedstaden, Denmark

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 27, 2024
Founded Date: 1923
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NYSE:NVO
Operating Status: Active

  • Marianne Hedegaard

    Service Manager (eDevice/eSolution in Clinical Trials)

    c****a@novonordisk.com

  • Maziar Mike Doustdar

    Executive Vice President, International Operations

    m**d@novonordisk.com

  • Unclassified inbox

    nnimediateam@novonordisk.com

  • Unclassified inbox

    janed@novonordisk.com

Show more 37 emails
View Novo Nordisk Profile Verify Novo Nordisk Emails Export Novo Nordisk Prospects

Novo Nordisk

novonordisk.com

HQ: Bagsværd, Hovedstaden, Denmark

HQ: Bagsværd, Hovedstaden, Denmark

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Aug 30, 2024
Founded Date: 1923
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NYSE:NVO
Operating Status: Active

  • Marianne Hedegaard

    Service Manager (eDevice/eSolution in Clinical Trials)

    c****a@novonordisk.com

  • Maziar Mike Doustdar

    Executive Vice President, International Operations

    m**d@novonordisk.com

  • Unclassified inbox

    nnimediateam@novonordisk.com

  • Unclassified inbox

    janed@novonordisk.com

Show more 37 emails
View Novo Nordisk Profile Verify Novo Nordisk Emails Export Novo Nordisk Prospects

Thermo Fisher Scientific

thermofisher.com

HQ: Waltham, MA

HQ: Waltham, MA

Specialized In: Biotechnology, Cloud Computing, Coaching & Consulting, Healthcare & Medical, Technology & Software

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 27, 2024
Founded Date: 1956
Company Type: For Profit
Stock Symbol: BMV:TMO
Operating Status: Active

  • Becky Moore

    Product Manager

    m***e@thermofisher.com

  • Kim Baltier

    Vice President, Global Commercial Operations Biosciences

    k*********r@thermofisher.com

  • Unclassified inbox

    orders@thermofisher.com

  • Unclassified inbox

    nniweborderconfirmations@thermofisher.com

Show more 29 emails
View Thermo Fisher Scientific Profile Verify Thermo Fisher Scientific Emails Export Thermo Fisher Scientific Prospects

Gilead Sciences

gilead.com

HQ: Foster City, California, United States

HQ: Foster City, California, United States

Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Manufacturing & Industrial

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: Jun 22, 1987
Number of Exits: 16
Company Type: For Profit
Stock Symbol: BIT:GILD
Operating Status: Active

  • Ahmed Afifi

    Vice President - Region Head Latin America

    a*********i@gilead.com

  • Kelsey Reedy

    Talent Advisor

    k**********y@gilead.com

  • Unclassified inbox

    public_affairs@gilead.com

  • Unclassified inbox

    bernard.murray@gilead.com

Show more 28 emails
View Gilead Sciences Profile Verify Gilead Sciences Emails Export Gilead Sciences Prospects

Bayer AG Germany

bayer.com

HQ: Leverkusen, Nordrhein-Westfalen, Germany

HQ: Leverkusen, Nordrhein-Westfalen, Germany

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public
Employees: 10001+
Rounds: Grant
Last Investment Activity: Mar 28, 2024
Founded Date: Aug 1, 1863
Number of Exits: 3
Company Type: For Profit
Stock Symbol: ETR:BAYN
Operating Status: Active

  • Annick D'haese

    MA

    a***********e@bayer.com

  • Christopher Yeechan

    Associate Director Procurement - API & Raw Materials

    c*****************n@bayer.com

  • General Inquiries

    info@bayer.com

  • Unclassified inbox

    olaf.zoellner.b@bayer.com

Show more 27 emails
View Bayer AG Germany Profile Verify Bayer AG Germany Emails Export Bayer AG Germany Prospects

AstraZeneca

astrazeneca.com

HQ: Cambridge, Cambridgeshire, United Kingdom

HQ: Cambridge, Cambridgeshire, United Kingdom

Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 23, 2024
Founded Date: Apr 6, 1999
Number of Exits: 11
Company Type: For Profit
Stock Symbol: NSE:ASTRAZEN
Operating Status: Active

  • Marc Dunoyer

    Chief Strategy Officer

    m**********r@astrazeneca.com

  • Richard Gallo

    Oncology Contract Strategy Manager

    r***********o@astrazeneca.com

  • General Inquiries

    contact@astrazeneca.com

  • General Inquiries

    help@astrazeneca.com

Show more 24 emails
View AstraZeneca Profile Verify AstraZeneca Emails Export AstraZeneca Prospects

Bayer

bayer.com

HQ: Whippany, New Jersey, United States

HQ: Whippany, New Jersey, United States

Specialized In: Biotechnology, Manufacturing & Industrial, Healthcare & Medical, Pharmaceuticals

Business Type: Private
Employees: 10001+
Last Investment Activity: Apr 1, 2024
Founded Date: Aug 1, 1863
Number of Exits: 3
Company Type: For Profit
Stock Symbol: ETR:BAYN
Operating Status: Active

  • Annick D'haese

    MA

    a***********e@bayer.com

  • Christopher Yeechan

    Associate Director Procurement - API & Raw Materials

    c*****************n@bayer.com

  • General Inquiries

    info@bayer.com

Show more 24 emails
View Bayer Profile Verify Bayer Emails Export Bayer Prospects

Bayer Fund

bayer.com

HQ: Whippany, New Jersey, United States

HQ: Whippany, New Jersey, United States

Specialized In: Biotechnology, Manufacturing & Industrial, Healthcare & Medical, Pharmaceuticals

Business Type: Private
Employees: 10001+
Last Investment Activity: Apr 1, 2024
Founded Date: Aug 1, 1863
Number of Exits: 3
Company Type: For Profit
Stock Symbol: ETR:BAYN
Operating Status: Active

  • Annick D'haese

    MA

    a***********e@bayer.com

  • Christopher Yeechan

    Associate Director Procurement - API & Raw Materials

    c*****************n@bayer.com

  • General Inquiries

    info@bayer.com

Show more 24 emails
View Bayer Fund Profile Verify Bayer Fund Emails Export Bayer Fund Prospects

Roche

roche.com

HQ: Basel, Basel-Stadt, Switzerland

HQ: Basel, Basel-Stadt, Switzerland

Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 27, 2024
Founded Date: Jan 15, 1896
Number of Exits: 3
Company Type: For Profit
Stock Symbol: SWX:ROG
Operating Status: Active

  • Jason Hall

    Senior Business Analyst

    j********l@roche.com

  • Thomas Schinecker

    t***************r@roche.com

  • Unclassified inbox

    patientcare@roche.com

  • Unclassified inbox

    new_zealand.dia_communications@roche.com

Show more 24 emails
View Roche Profile Verify Roche Emails Export Roche Prospects

Bristol-Myers Squibb

bms.com

HQ: New York, NY

HQ: New York, NY

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 28, 2024
Founded Date: 1887
Number of Exits: 14
Company Type: For Profit
Stock Symbol: NYSE:BMY
Operating Status: Active
Investor Type: Venture Capital

  • John damonti

    Foundation President

    d******j@bms.com

  • Ron Behling

    r************g@bms.com

  • Unclassified inbox

    drugsafety@celgene.com

  • Unclassified inbox

    carmen.m.lopez@bms.com

Show more 22 emails
View Bristol-Myers Squibb Profile Verify Bristol-Myers Squibb Emails Export Bristol-Myers Squibb Prospects

Celgene

bms.com

HQ: Summit, New Jersey, United States

HQ: Summit, New Jersey, United States

Specialized In: Biotechnology, Healthcare & Medical

Acquired by: Bristol-Myers Squibb
Business Type: Delisted
Employees: 10001+
Last Investment Activity: May 24, 2024
Founded Date: 1986
Number of Exits: 31
Company Type: For Profit
Stock Symbol: NASDAQ:CELG
Operating Status: Active

  • John damonti

    Foundation President

    d******j@bms.com

  • Ron Behling

    r************g@bms.com

  • Unclassified inbox

    drugsafety@celgene.com

Show more 21 emails
View Celgene Profile Verify Celgene Emails Export Celgene Prospects

University of California, San Francisco

ucsf.edu

HQ: San Francisco, CA

HQ: San Francisco, CA

Specialized In: Biotechnology, Education & E-learning, Healthcare & Medical, Pharmaceuticals

Business Type: Private
Employees: 10001+
Rounds: Grant
Last Investment Activity: Nov 21, 2023
Founded Date: 1873
Company Type: For Profit
Operating Status: Active

  • Judy Kim

    j******m@ucsf.edu

  • Sunita Mutha

    Professor of Medicine

    s**********a@ucsf.edu

  • Media Relations

    socialmedia@ucsf.edu

  • Unclassified inbox

    ucsf.msa.juma@ucsf.edu

Show more 21 emails
View University of California, San Francisco Profile Verify University of California, San Francisco Emails Export University of California, San Francisco Prospects

GlaxoSmithKline

gsk.com

HQ: London, England, United Kingdom

HQ: London, England, United Kingdom

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public
Employees: 10001+
Rounds: Grant
Last Investment Activity: Mar 1, 2024
Founded Date: 1929
Number of Exits: 14
Company Type: For Profit
Stock Symbol: NYSE:GSK
Operating Status: Active

  • Magnus Hibbert

    m************t@gsk.com

  • Warren Carin

    w**********n@gsk.com

  • Unclassified inbox

    askus@gsk.com

  • Unclassified inbox

    manuel.m.bermudez@gsk.com

Show more 20 emails
View GlaxoSmithKline Profile Verify GlaxoSmithKline Emails Export GlaxoSmithKline Prospects

Quintiles

quintiles.com

HQ: Durham, NC

HQ: Durham, NC

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Acquired by: IMS Health
Business Type: Delisted
Employees: 10001+
Rounds: Grant
Last Investment Activity: Jan 22, 2024
Founded Date: 1982
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:Q
Operating Status: Active

  • Saida El Maslouhi, MSc.

    Director Early Clinical Development

    s**************i@quintiles.com

  • Darren Coish

    d**********h@quintiles.com

  • Unclassified inbox

    mallika.bhaskar@quintiles.com

  • Unclassified inbox

    matthew.frese@quintiles.com

Show more 19 emails
View Quintiles Profile Verify Quintiles Emails Export Quintiles Prospects

University of California, San Francisco

ucsf.edu

HQ: San Francisco, CA

HQ: San Francisco, CA

Specialized In: Biotechnology, Education & E-learning, Healthcare & Medical, Pharmaceuticals

Business Type: Private
Employees: 10001+
Rounds: Grant
Last Investment Activity: Nov 21, 2023
Founded Date: 1873
Company Type: For Profit
Operating Status: Active

  • Judy Kim

    j******m@ucsf.edu

  • Sunita Mutha

    Professor of Medicine

    s**********a@ucsf.edu

  • Media Relations

    socialmedia@ucsf.edu

Show more 18 emails
View University of California, San Francisco Profile Verify University of California, San Francisco Emails Export University of California, San Francisco Prospects